Upon investigating the correlation between immune cell density and the immune and cancer pathway scores derived from transcriptome data, we found that both immune cell density and immune pathway scores correlated positively with cancer pathway scores in the recur group; an exception was the NF-kB signaling pathway. Here, NFKB1 is linked to cancer.